Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023
Revenues188m258m321m532m
% growth-37 %24 %66 %
EBITDA(169m)(220m)(237m)(133m)
% EBITDA margin(90 %)(85 %)(74 %)(25 %)
Profit(210m)(259m)(290m)(214m)
% profit margin(112 %)(101 %)(90 %)(40 %)
R&D budget91.3m128m162m185m
R&D % of revenue49 %50 %51 %35 %
  • Edit
DateInvestorsAmountRound
-

N/A

-

$100m

Valuation: $5.0b

Series G

$200m

Valuation: $8.1b

Series G
*
N/A

$100m

Valuation: $8.1b

Late VC
*

$175m

Debt
*
N/A

$472m

Valuation: $6.6b

IPO
Total Funding$920m

Recent News about Tempus

Edit
More about Tempus
Edit

Tempus is a healthcare technology startup that leverages data and artificial intelligence (AI) to improve patient outcomes. The company operates in the healthcare and biotech industry, serving a diverse range of clients including physicians, pharmaceutical and biotech companies, and patients.

The company's primary offering is a proprietary platform that uses AI to analyze medical data. This platform helps physicians make more informed treatment decisions by providing actionable insights from medical images and identifying gaps in patient care. For pharmaceutical and biotech companies, Tempus assists in drug development by discovering novel targets and evaluating the effectiveness of treatments. Patients benefit from the platform's ability to identify personalized therapy options.

Tempus also conducts extensive research, with a focus on cancer. The company's studies have revealed that their platform can increase personalized therapeutic opportunities for cancer patients. They have developed a pan-cancer organoid platform for precision medicine and validated a liquid biopsy assay for molecular and clinical profiling of circulating tumor DNA.

The company's business model is based on providing these services to healthcare providers and companies. They generate revenue by charging for access to their platform and the insights it provides.

In summary, Tempus is a healthcare tech startup that uses AI and data analysis to improve patient care and assist in drug development.

Keywords: Healthcare Technology, Artificial Intelligence, Data Analysis, Patient Care, Drug Development, Physicians, Pharmaceutical Companies, Biotech Companies, Cancer Research, Personalized Therapy.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Tempus

Edit
Highline Sciences
ACQUISITION by Tempus Feb 2022